Echocardiography and myocardial viability;Ecocardiografía y viabilidad miocárdica

Revista Espanola de Cardiologia

Volumn 50, Issue SUPPL. 5, 1997, Pages 49-58

  Vázquez, Jesús Peteiro ^a,b  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b NONE   (Spain)

Author keywords

Dobutamine stress echocardiography; Left ventricular dysfunction; Myocardial viability

Indexed keywords

EID: 2542505580     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Lenderick T, Simoons ML, Gerrit-Anne VE, Van Der Werf F, Verstraete M, Arnold AER. European Cooperative Study Group. Benefit of thrombolityc therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation 1995; 92: 1.110-1.116.
2. Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336.
3. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983; 68: 321-336.
4. De Busck RF. Specialized testing in recent acute myocardial infarction. Ann Intern Med 1989; 110: 470-481.
5. Rahimtoola SH. Coronary by-pass surgery for chronic angina-1981: a perspective. Circulation 1982; 65: 225-241.
6. Rahimtoola SH. Hibernating miocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996; 94: 3.055-3.061.
7. Vanoverschelde J-L J, Wijns W, Depré Ch, Essamri B, Heyndrikx GR, Borgers M et al. Mechanisms of chronic regional post-ischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1.513-1.523.
8. Sun KT, Czernin J, Krirokapich J, Yuk-Kong-Lau, Bötcher M, Maurer G et al. Effects of Dobutamine stimulation on myocardial blood flow, glucose metabolism and wall motion in normal and dysfunctional myocardium. Circulation 1996; 94: 3.146-3.154.
9. Faletra F, Crivellaro W, Pirelli S, Parodi O, De Chiara F, Cipriani M et al. Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed q-wave anterior wall myocardial infarction. Am J Cardiol 1995; 76: 1.002-1.006.
10. Vanoverschelde J-L J, Gerber BL, D'Hont A-M, De Kock M, Dion R, Wijns W et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose Dobutamine echocardiography and exercise-redistribution-reinjection thallium spect. Circulation 1995; 95 (Supl 12): 37-44.
11. Oh H, Ito H, Iwakura K, Masuyama T, Takiuchi S, Maruyama A et al. Temporal changes in regional end-diastolic wall thickness early after reperfusion in acute anterior myocardial infarction: Relation to myocardial viability and vascular damage. Am Heart J 1996; 131: 1.113-1.120.
12. Zhang J, Path G, Chepuri V, Homans DC, Merckle H, Hendrich K et al. Effects of Dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: implications with regard to dobutamine stress testing. Am Heart J 1995; 129: 330-342.
13. Pierard LA, De Landsheere CHM, Berthe CH, Rigo P. Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1.021-1.031.
14. Smart SC, Sawada S, Ryan Th. Segar D, Atherton L, Berkovitz K et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405-415.
15. Salustri A, Elhendy A, Garyfallydis P, Ciavatti M, Cornel JH, Ten Cate FJ et al. Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 1994; 74: 853-856.
16. Watada H, Ito H, Oh H, Masuyama T, Aburaya M, Hori M et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversible damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994; 24: 624-630.
17. Marzullo P, Parodi O, Reisenhofer B, Sambuceti G, Picano E, Distante A et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial vaibility. Am J Cardiol 1993; 71: 166-172.
18. La Canna G, Alfieri O, Giubinni R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23: 617-626.
19. Arnese M, Cornel JH, Salustri A, Maat A, Elhendy A, Rejis AE et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201-thallium single-photon emission computed tomography. Circulation 1995; 91: 2.748-2.752.
20. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betochi S, Squame F et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91: 2.556-2.565.
21. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995; 91: 663-670.
22. Armstrong W. «Hibernating» myocardium: asleep or part dead? J Am Coll Cardiol 1996; 28: 530-535.
23. Kaul S. Response of dysfunctional myocardium to dobutamine. «The eyes see what the mind knows!» J Am Coll Cardiol 1996; 27: 1.608-1.611.
24. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lespearance J. Long-term fate of by-pass grafts: The Coronary Artery Surgery Study (CASS) and the Montreal Institute experience. Circulation 1985; 72 (Supl 5): 71.
25. Afridi I, Main ML, Grayburn PA. Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with an occluded left anterior descending coronary artery. J Am Coll Cardiol 1996; 28: 455-459.
26. Sawada S, Elsner G, Segar DS, O'Shaug Hnessy M, Khouri S, Foltz J et al. Evaluation of patterns of perfusion and metabolism in Dobutamine-responsive myocardium. J Am Coll Cardiol 1997; 29: 55-61.
27. Senior R, Lahiri A. Enhanced detection of miocardial ischemia by stress dobutamine echocardiography utilizing the «Diphasic» response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995; 26: 26-32.
28. Olson CH, Porter ThR, Deligonul U, Xie F, Anderson JR. Left ventricular volume changes during dobutamine stress echocardiography identify patients with more extensive coronary artery disease. J Am Coll Cardiol 1994; 24: 1.268-1.273.
29. Weissman NJ, Nidorf SM, Guerrero L, Weyman AE, Picard MH. Optimal stage duration in dobutamine stress echocardiography. J Am Coll Cardiol 1995; 25: 605-609.
30. Cornel JH, Balk AHMM, Boersma E, Maat AP, Elhendy A, Arnese M et al. Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction. J Am Soc Echocardiogr 1996; 9: 27-32.
31. Sharp SM, Sawada S, Segar DS, Ryan Th, Kovacs R, Fineberg NS et al. Dohutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 1994; 24: 934-939.
32. Vigna C, Russo A, De Rito V, Perna GP, Testa M, Lombarde A et al. Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and non ischemic dilated cardiomyopathy. Am Heart J 1996; 131: 537-543.
33. Williams MJ, Odabashian I, Lauer MS, Thomas JD, Marwick ThM. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27. 132-139.
34. Sicari R, Picano E, Landi P, Pingitore A, Bigi R, Coletta C et al. Echo Dobutamine International Cooperative (EDIC) Study. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol 1997; 29: 254-260.
35. Picano E, Marzullo P, Gigli G, Reisenhofer B, Parodi O, Distante A et al. Identification of viable myocardium by dipiridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with tallium scintigraphy at rest. Am J Cardiol 1992; 70: 703-710.
36. Picano E, Ostojic M, Varga A, Sicari R, Djordjevic-Dikic A, Nedeljkovic I et al. Combined low-dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol 1996; 27: 1.422-1.428.
37. Valentine V, Pappas E, Parker M, Bonow R, Chandhry F. Does nitroglycerine enhance the identification of viable myocardium by dobutamine echocardiography? [resumen] J Invest Med 1995; 43; 390A.
38. Tidgren B, Hjemdahl P, Theodorsson E, Nussberger J. Renal, neurohumoral and vascular responses to dynamic exercise in humans. J Appl Physiol 1991; 70: 2.279-2.286.
39. Bolognese L, Antoniucci D, Rovai D, Buonamici P, Cerisano G, Santoro GM et al. Myocardial contrat echocardiography versus dobutamine echocardiography for predicting functional recovery acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1996; 28: 1.677-1.683.
40. Von Bibra H, Tuchnitz A, Frischke Ch, Schühlen, Schömig A. Doppler tissue imaging of left ventricular myocardium-initial results during farmacological stress [resumen] J Am Coll Cardiol 1995; P57A.
41. Buck Th, Drozdz J, Schön F, Leischik R, Baumgart D, Ge J et al. Use of color-coded tissue Doppler for dobutamine-stress-echocardiography [resumen] J Am Coll Cardiol 1995; P57A.
42. Bolli R, Lekich RF, Myers ML, Hartley CJ, Roberts R. Disparity of epicardial and endocardial function during ischemia and reperfusion [resumen]. Circulation 1984; 70: 260.
43. García-Fernández M, Azebedo J, Puerta P, Moreno M, San Román D, Torrecilla E et al. Regional left ventricular diastolic dysfunction evaluated by tissue Doppler imaging as an earlier signal of myocardial ischemia. Experimental study of induced ischemia and reperfusion in pigs [resumen] J Am Coll Cardiol 1996; 27: P299A.
44. Madaras EI, Barzilai M, Pérez JE, Sobel BE, Miller JG. Changes in myocardial backscatter throughout the cardiac cycle. Ultrason Imag 1983; 36: 5: 229-239.
45. Barzilai B, Madaras EI, Sobel BE, Miller JG, Pérez JE. Effects of myocardial contraction on ultrasonic backscatter before and after ischemia. Am J Physiol 1984; 247: H478-H483.
46. Gluek RM, Mottley JG, Miller JG, Sobel BE, Pérez JE. Effect of coronary artery occlusion and reperfusion on cardiac cycle dependence variation of myocardial integrated backscatter. Cir Res 1985; 56: 683-689.
47. Wickline SA, Thomas LJIII, Miller JG, Sobel BE, Pérez JE. Sensitive detection of the effects of reperfusion on myocardium by ultrasonic tissue characterization with integrated backscatter. Circulation 1986; 74: 389-400.
48. Milunski MR, Mohr GA, Pérez JE, Vered Z, Wear KA, Gessler CJ et al. Ultrasonic tissue characterization with integrated backscatter: acute myocardial ischemia, reperfusion and stunned myocardium in patients. Circulation 1989; 80: 491-503.
49. Naito J, Masuyama T, Mano, Kondo H, Doi Y, Yamamoto K et al. Dobutamine stress ultrasonic myocardial characterization in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 1996; 9: 470-479.
50. Vered Z, Mohr GA, Barzilai B, Gessler CJ Jr. Wickline SA, Wear KA et al. Ultrasonic integrated backscatter tissue characterization of remote myocardial infarction in human subjects. J Am Coll Cardiol 1989; 13: 84-91.
51. Vered Z, Barzilai B, Mohr GA, Thomas LJ, Genton R, Sobel BE et al. Quantitative ultrasonic tissue characterization with realtime integrated backscatter imaging in normal subjects and in patients with dilated cardiomyopathy. Circulation 1987; 76: 1.067-1073.
52. Pérez JE, McGill JB, Santiago JV, Schechtman KB, Wagonner AD, Miller JG et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 1992; 19: 1.154-1.162.
53. Pérez JE, Waggoner AD, Thomas L, Melton HE, Davila-Roman V. Real-time quantitation of left ventricular areas during dobutamine stress echocardiography [resumen]. J Am Soc Echocardiogr 1991; 4: 280.
54. Madaras EI, Pérez JE, Sobel BE, Mottley JG, Miller JG. Anisotropy of the ultrasonic backscatter of myocardial tissue, II: measurements in vivo. J Acoust Soc Am 1988; 83: 762-769.
55. Meltzer RS, Ohad DG, Reisner SH, Sucher E, Kaplinsky E, Motro M et al. Quantitative myocardial ultrasonic integrated backscatter measurements during contrast injections. J Am Soc Echocardiogr 1994; 7: 1-8.